ATOM

Sponsor: University of Oxford

ClinicalTrials.gov Number: NCT02628080

 

Atovaquone as Tumour HypOxia Modifier

Full title: Pre-operative window of opportunity study of the effects of atovaquone on hypoxia in non-small cell lung carcinoma

 

STUDY DESIGN

Open label window of opportunity study

STUDY POPULATION

Patients with suspected non-small cell lung cancer (NSCLC)

I'd like to Know More

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Pages

About Us
We aim to enhance clinical and basic cancer research in Oxford with the ultimate goal of increasing cancer cure rates.
Research
In Oxford, we have a great wealth of broad-ranging expertise and a powerful network of cancer researchers.
Study With Us
Our graduate training programmes for both scientists and clinicians are internationally recognised.
Subscribe to Department of Oncology RSS